ArticleMolecular therapy : the journal of the American Society of Gene Therapy2026
A precision gene-engineered B cell medicine producing sustained levels of active factor IX for hemophilia B therapy.
Hanlan Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it